UAE Plasma Fractionation Market Size & Outlook, 2022-2030
The plasma fractionation market in the UAE is expected to reach a projected revenue of US$ 543.6 million by 2030. A compound annual growth rate of 7.1% is expected of the UAE plasma fractionation market from 2023 to 2030.
Revenue, 2022 (US$M)
$314.4
Forecast, 2030 (US$M)
$543.6
CAGR, 2023 - 2030
7.1%
Report Coverage
UAE
UAE plasma fractionation market, 2018-2030 (US$M)
Related Markets
UAE plasma fractionation market highlights
- The UAE plasma fractionation market generated a revenue of USD 314.4 million in 2022 and is expected to reach USD 543.6 million by 2030.
- The UAE market is expected to grow at a CAGR of 7.1% from 2023 to 2030.
- In terms of segment, immunoglobulins was the largest revenue generating product in 2022.
- Coagulation Factors is the most lucrative product segment registering the fastest growth during the forecast period.
Plasma fractionation market data book summary
| Market revenue in 2022 | USD 314.4 million |
| Market revenue in 2030 | USD 543.6 million |
| Growth rate | 7.1% (CAGR from 2022 to 2030) |
| Largest segment | Immunoglobulins |
| Fastest growing segment | Coagulation Factors |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Albumin, Immunoglobulins, Coagulation Factors, Protease inhibitors, Others (thrombin, protein C, antithrombin) |
| Key market players worldwide | Grifols SA Ordinary Shares - Class A, CSL Ltd, Takeda Pharmaceutical Co Ltd, Biotest AG ADR, Octapharma AG, Kedrion Biopharma, LFB (Laboratoire Français du Fractionnement et des Biotechnologies), Bio Products Laboratory, Intas Pharmaceuticals |
Other key industry trends
- In terms of revenue, UAE accounted for 1.0% of the global plasma fractionation market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, UAE plasma fractionation market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 341.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Plasma Fractionation Market Scope
Plasma fractionation market segmentation & scope
Albumin
Intravenous immunoglobulins
Subcutaneous immunoglobulins
Other immunoglobulins
Factor VIII
Factor IX
VON WILLEBRAND FACTOR
PROTHROMBIN COMPLEX CONCENTRATES
FIBRINOGEN CONCENTRATES
Others (FACTOR XIII, FACTOR XI)
Protease inhibitors
Others (thrombin, protein C, antithrombin)
Cetrifugation
Depth Filtration
Chromatography
Others (ethanol Fractionaation, cryoprecipitation, ultrafiltration)
Plasma Fractionation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE plasma fractionation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasma fractionation market will help companies and investors design strategic landscapes.
Immunoglobulins was the largest segment with a revenue share of 61.1% in 2022. Horizon Databook has segmented the UAE plasma fractionation market based on albumin, immunoglobulins, coagulation factors, protease inhibitors, others (thrombin, protein c, antithrombin) covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to UAE plasma fractionation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE plasma fractionation market databook
-
Our clientele includes a mix of plasma fractionation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE plasma fractionation market , including forecasts for subscribers. This country databook contains high-level insights into UAE plasma fractionation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UAE plasma fractionation market size, by product, 2018-2030 (US$M)
UAE Plasma Fractionation Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
